ArticlePDF AvailableLiterature Review

Effectiveness and Safety of Arnica Montana in Post-Surgical Setting, Pain and Inflammation


Abstract and Figures

Arnica montana has been widely used as a homeopathic remedy for the treatment of several inflammatory conditions in pain management and postoperative settings. This review gives an overview of the therapeutic use of Arnica montana in the above-mentioned fields also focusing on its mechanisms of action learned from animal models and in vitro studies. Arnica montana is more effective than placebo when used for the treatment of several conditions including post-traumatic and postoperative pain, edema, and ecchymosis. However, its dosages and preparations used have produced substantial differences in the clinical outcome. Cumulative evidence suggests that Arnica montana may represent a valid alternative to non-steroidal anti-inflammatory drugs, at least when treating some specific conditions.
Content may be subject to copyright.
Effectiveness and Safety of Arnica montana in Post-Surgical
Setting, Pain and Inflammation
Tommaso Iannitti, PhD,
esar Morales-Medina, PhD,
Paolo Bellavite, MD,
Valentina Rottigni, MSC,
and Beniamino Palmieri, MD, PhD
Arnica montana has been widely used as a homeopathic remedy for the treatment of several inflam-
matory conditions in pain management and postoperative settings. This review gives an overview of
the therapeutic use of Arnica montana in the above-mentioned fields also focusing on its mechanisms
of action learned from animal models and in vitro studies. Arnica montana is more effective than
placebo when used for the treatment of several conditions including post-traumatic and postoper-
ative pain, edema, and ecchymosis. However, its dosages and preparations used have produced
substantial differences in the clinical outcome. Cumulative evidence suggests that Arnica montana
may represent a valid alternative to non-steroidal anti-inflammatory drugs, at least when treating
some specific conditions.
Keywords: Arnica montana, homeopathy, herbal medicine, side effect profile, inflammation, pain,
surgery, trauma, ecchymosis, edema
The use of complementary therapies, including plant
remedies, is widespread and rapidly expanding on
a worldwide scale. Plant remedies are traditionally
used in a variety of pharmacopoeias and on a large
scale of doses, including extremely low-dose homeo-
pathic formulations. Herbal medicine or botanical
medicine or phytomedicine refers to the therapeutic
use of herbs, herbal materials, herbal preparations,
and finished herbal products containing plant
materials (seeds, berries, roots, leaves, bark, or flow-
ers) or parts as active ingredients. Homeopathy is
based on the concept similia similibus curentur
according to which symptoms, caused by the origi-
nal substance in healthy subjects, can be reversed by
the homeopathic remedy in patients having similar
symptoms. Therefore, homeopathic drug adminis-
tration is based on 3 principles: (1) the administra-
tion of an active element to healthy volunteers
brings manifestation of a series of clinical symptoms
at physical and psychological levels; (2) low doses of
thesameelement(s)reversepathological states in ill
organisms presenting a similar symptomatologic
pattern; (3) the homeopathic treatment retains its
biological activity because of a peculiar method of
dilution followed by vigorous shaking, that is, suc-
cussion, even if, after several successive serial dilu-
tions, the probability of the presence of any active
molecule is very low.
There are several models
attempting to explicate how the peculiar homeo-
pathic procedure of succussion can change solvent
structure at nanoscopic level and justify the perma-
nence of pharmacological properties throughout di-
School of Biomedical Sciences, University of Leeds, Leeds, United
Douglas Mental Health Research Institute, McGill
University, Montreal, Quebec, Canada;
Department of Pathology
and Diagnostics, University of Verona, Verona, Italy; and
Department of Surgery and Surgical Specialties, University of
Modena and Reggio Emilia Medical School, Surgical Clinic,
Modena, Italy.
The authors contributed equally to this work.
The authors have no conflicts of interest to declare.
*Address for correspondence: School of Biomedical Sciences, Uni-
versity of Leeds, Mount Preston St, Garstang building, Leeds, LS2
9JT, United Kingdom. E-mail:
American Journal of Therapeutics 23, e184–e197 (2016)
10752765 Copyright © 2014 Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 201 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Arnica is one of the most popular medications in
complementary medicine. This remedy can be ex-
tracted from several plant species belonging to the
Aesteraceae family including Arnica montana,Arnica
chamissonis,Arnica fulgens,Arnica cordifolia and Arnica
sororia, and it is widely sold as tincture, ointment,
cream, gel, and tablet. In 2009, a study showed that
Asteracea-containing remedies were frequently used
in German primary care, and their uses were not asso-
ciated with serious adverse reactions.
Arnica can be
used as a homeopathic or herbal remedy. There are
also Arnica-based complex formulations which can
include up to 32 different plant species which share
morphological characteristics and therapeutic proper-
ties to treat inflammation, wounds, hematoma, and
Among the different varieties, Arnica mon-
tana L. is one of the most used varieties and receives
different local names including leopards bane, wolfs
bane, mountain tobacco, and mountain snuff.
herb (here referred as Arnica), native of the Siberian
mountains and Central Europe, has been used for the
treatment of numerous pathological conditions,
including pain, stiffness, and swelling associated with
trauma, contusions, sprains, myocarditis, cardiac
insufficiency, arteriosclerosis, angina pectoris, postop-
erative clinical conditions, and for symptomatic relief
in osteoarthritis.
In traditional medicine, patients
suffering from traumatic disease often use Arnica as an
alternativetreatment, in the hope of resolving pain
and reducing the use of conventional drugs which
may cause adverse effects. Furthermore, according to
a review concerning the use of alternative and comple-
mentary medicine for rheumatological conditions such
as osteoarthritis, rheumatoid arthritis, and fibromyal-
gia, Arnica was used in 18% of patients attending the
rheumatology department in a Mexican hospital.
vitro studies have shown that the most active compo-
nents of Arnica, as well as of other members of the
Asteraceae family, are helenalin and other sesquiter-
pene lactones such as 11a,13-dihydrohelenalin and
chamissonolid. Early on, Lyss et al
showed that hel-
enalin inhibits the transcriptional factor nuclear factor
kappa B (NF-kB) through the alteration and stabiliza-
tion of the NF-kB/inhibitor of kappa B (IkappaB) com-
plex in T cells, B cells, and epithelial cells and
abrogates kappa B-driven gene expression. This repre-
sents one of the earliest evidences of the anti-
inflammatory properties of Arnica. Later work showed
that helenalin can inhibit human neutrophil migration
and chemotaxis
and activities of 5-lipoxygenase and
leukotriene C4 synthase.
Helenalin dose-
dependently reduced cell-proliferation in cluster of dif-
ferentiation (CD)4
T cells after the activation of the
mitochondrial apoptosis pathway and p53 rapid
stabilization and nuclear localization.
it arrested activated CD4
T cell cycle in the G2/M
phase through an increase in p27
, p21
and cyclin D2, and a decrease in cyclin B1 and cyclin
Helenalin also decreased the expression of cell-
surface receptors CD25, CD28, CD27, and CD120b
which play a key role in NF-kB activation in T cells,
supporting the mechanism proposed by Lyss et al in
NF-kB controls the transcription of various
cytokine and adhesion molecule genes in addition to
genes required for antigen presentation.
NF-kB acti-
vation is associated with the induction of pain and
inflammation, as observed in animal models of inflam-
matory pain (rat carrageenan pleurisy and mouse car-
rageenan air pouch), characterized by the release of
proinflammatory cytokines (tumor necrosis factor-alpha
[TNF-a] and interleukin-1beta [IL-1b]) and local recruit-
ment of leukocytes.
The ability of Arnica to inhibit
activation of transcription factors NF-kBandnuclear
factor of activated T cells and proinflammatory cyto-
kines IL-1band TNF-acorrelate with their quantitative
and qualitative content of sesquiterpene lactones.
Additionally, Arnica treatment showed a 4.5-fold inhi-
bition of nitric oxide production, a reduction in the
levels of inducible nitric oxide synthase and
cyclooxygenase-2 protein, a 3-fold reduction in TNF-a
level, and prevented nuclear translocation of NF-kBin
J774 murine macrophage cells challenged with lipopoly-
Furthermore, in the rat, 21-day oral treat-
ment with Arnica 30
centesimal dilution (30c)
protected against hepatic mitochondrial membrane
FIGURE 1. Mechanisms underlying Arnica effectiveness.
COX-2, cyclooxygenase-2; TNF-a, tumor necrosis factor
alpha; IL-1b, interleukin-1 beta; NO, nitric oxide; iNOS,
inducible nitric oxide synthase; NF-kB, nuclear factor
kappa B; IkB, inhibitor of kappa B.
Effectiveness and Safety of Arnica montana e185 American Journal of Therapeutics (2016) 23(1)
Copyright © 201 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
permeabilization induced by Ca
and/or Fe
mediated lipid peroxidation and fragmentation of pro-
teins due to attacks by reactive oxygen species.
Figure 1, we have summarized the mechanisms under-
lying Arnica effectiveness. As an herbal formulation,
Arnica is generally used only topically (on the skin)
because of side effects which can be observed after oral
administration. Oral homeopathic remedies do contain
Arnica, but they use an extremely diluted form which is
not considered dangerous. The literature concerning
Arnica in both phytotherapeutic and homeopathic for-
mulations is rapidly increasing, together with the
knowledge of its active principles and putative mecha-
nisms of action. In this review, we grouped clinical evi-
dence into 2 sections. The first group comprises the use
of Arnica as topical formulation, either as a phytother-
apic extract (higher dosage not succussed) or homeo-
therapic (diluted and succussed preparations), whereas
the second group comprises the use of homeopathic
preparations administered by oral or topical route.
The focus was on preclinical and clinical use of Arnica
for the treatment of inflammatory conditions, in pain
management and postoperative settings.
This review gives an overview of the literature in the
aforementioned fields, from 1997 to 2013. The princi-
pal information sources are drawn from current read-
ing of major complementary and alternative medicine
journals, screening of the Hom-Inform Bibliographic
Database and Information Service Databases (British
Homeopathic Library, http://hominform.soutron.
com/), literature search using MEDLINE, the
Cochrane Database of Systematic Reviews, and cross-
referencing among published articles. Our analysis
includes controlled clinical trials (with and without
randomization), observational studies, and case series,
but it excludes single case reports. We also consulted
previously published systematic reviews and meta-
analyses which have covered the subject up to now.
Finally, some relevant studies concerning the mecha-
nism(s) of action and laboratory studies are reported.
Arnica hasbeenusedasasingleremedy
in preclinical
models of acute (carrageenan- and homologous blood
induced rat paw edema) and chronic (nystatin-induced
rat paw edema) inflammation and histamine-induced
increased vascular permeability.
For instance, autol-
ogous blood-induced edema was reduced 1, 3, and 5
hours after subplantar but not after oral administration
of Arnica 4th decimal dilution (4D), when compared with
control animals.
Lussignoli et al
replicated this finding
and showed that administration of Arnica alone or as
a homeopathic formulation (Traumeel) an hour before
or after the injection of autologous blood, decreased
in paw edema coupled with a decrease in systemic
interleukin-6 (IL-6) at 5 hours after blood edema induc-
Subchronic oral administration of Arnica 6c also
reduced carrageenan-induced rat paw edema by 30%.
The reduction in paw edema was evident starting from
1 hour post-carrageenan, and lasted at least 6 hours. In
the same study, oral treatment with Arnica 6c before 8.5%
nystatin-induced inflammation showed a reduction in the
edema at 6 hours compared with the control group.
However, no effect was observed when adminis-
tered after nystatin. Furthermore, Arnica 6c blocked
histamine-induced increase in vascular permeability
when administered 3 days before stimulus. Oral Arnica
6c administered every 15 minutes between 30 and 180
minutes, after 1% kappa carrageenan inoculation, was
effective in reducing late but not early edema in the rat
when compared with control groups.
Edema ameliora-
tion coupled with a decrease in the mast cell degranula-
tion and an increase in the lymphatic vessel diameter.
Helenalin, a sesquiterpene lactone and one of the
main active constituent of Arnica extract,
carrageenan-induced paw edema and complete Freunds
adjuvant-induced arthritis in the rat.
Topical application
of Arnica 3D gel (10%), combined with microcurrent
(10 mA for 2 minutes) application, significantly improved
wound healing in the linear incision wound model in the
rat back.
The evidence was consistent with a signifi-
cantly larger total number of cells and higher percentage
of mature collagen fibers in the wound, as assessed by
structural and morphometric analysis. Therefore, these
results strongly support the relevance of Arnica in the
treatment of inflammatory-related processes.
Topical applications of phytotherapeutic
Up to now, several clinical trials involving the use of
topical Arnica have been performed aiming to reduce
laser-induced bruising and osteoarthritis-related symp-
toms. We have summarized these studies in Table 1.
Laser-induced bruising
Daily application of 2 extracts based on a combination
of Arnica and stinging nettle (Combudoron liquid and
Combudoron gel; 0.5 mL per lesion for 30 minutes for
e186 Iannitti et al
American Journal of Therapeutics (2016) 23(1)
Copyright © 201 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Table 1. Clinical efficacy of Arnica montana.
year Design No. Patients Pathology Treatment Outcome Homeopathy
118 Post-surgical
after removal
of impacted
wisdom teeth
Arnica 200c versus
versus placebo
Metronidazole was more
effective in pain control
(P,0.001 and P,0.01),
swelling prevention
(P,0.01 and P,0.05)
and healing promotion
(P,0.01 and P,0.01)
when compared with
Arnica and placebo,
30 Dental neuralgic
pain after
Arnica 7c and
Hypericum 15c
versus placebo
76% of the
patients treated with
homeopathic remedies
had pain relief versus
40% of patients
receiving placebo
Zell et al,
69 Acute sprains of
the ankle joint
ointment versus
24 patients were pain-free
on treatment day 10,
whereas on the same
day, only 13 patients
treated with placebo had
no pain
et al,
clinical study
39 Prolonged
Arnica 5c Arnica reduced pain,
hyperemia, edema, and
hematoma formation.
Improvement in the blood
flow and slight increase in
coagulation factors and in
platelet aggregation were
observed after Arnica
et al,
clinical trial
18 Blood
Arnica 5c versus
An increase in bleeding time
and a decrease in
fibrinogen were observed
30 minutes after Arnica
Lokken et al,
24 Pain after
removal of
third molars
Arnica 30D versus
No difference in
postsurgical pain was
observed between Arnica
and placebo.
Postoperative swelling
and bleeding were not
significantly affected by
Hart et al,
73 Pain and
recovery after
Arnica 30c versus
No significant difference
was observed between
Arnica and placebo
Vickers et al,
400 Muscle soreness
after long-
Arnica 30D versus
No significant change in
muscle soreness after
long-distance running
was observed when
comparing Arnica to
(Continued on next page)
Effectiveness and Safety of Arnica montana e187 American Journal of Therapeutics (2016) 23(1)
Copyright © 201 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Table 1. (Continued) Clinical efficacy of Arnica montana.
year Design No. Patients Pathology Treatment Outcome Homeopathy
et al,
130 Saphenous
Arnica 5c versus
No significant difference in
hematomas was
observed between
Arnica and placebo
Alonso et al,
19 Laser-induced
Arnica gel versus
No difference was
observed between
Arnica and vehicle
administered prior or
after injury
Jeffrey and
37 Hand surgery
carpal tunnel
Arnica 6D tablets
and Arnica
ointment versus
No difference in grip
strength or wrist
circumference was
found between Arnica
and placebo. A
significant reduction in
pain was observed in
the Arnica-treated group
versus placebo.
et al,
79 Mild–moderate
Arnica gel Median total scores on the
Western Ontario and
McMaster Osteoarthritis
Index were significantly
decreased in the
intention-to-treat and per-
protocol populations
(both P,0.0001). Scores
on the pain, stiffness, and
function subscales were
also signifcantly
Wolf et al,
pilot trial
60 Varicose vein
Arnica 12D versus
Hematoma surface was
reduced with Arnica
by 75.5% and with
placebo by 71.5%
(not significant). Pain
score decreased by
162.2 points with
Arnica and 0.3 60.8
points with placebo not
The results of the study
showed a trend
towards a beneficial
effect of Arnica
regarding the
reduction in hematoma
and pain during the
postoperative course
et al,
62 Surgery for
carpal tunnel
Arnica 6c or 30c
versus placebo
No significant change in
pain and bruising were
observed after
administration of Arnica
or placebo
(Continued on next page)
e188 Iannitti et al
American Journal of Therapeutics (2016) 23(1)
Copyright © 201 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Table 1. (Continued) Clinical efficacy of Arnica montana.
year Design No. Patients Pathology Treatment Outcome Homeopathy
Tveiten and
82 Muscle soreness
and cell
damage after
Arnica versus
Muscle soreness
immediately after the
marathon was lower in
the Arnica group versus
placebo (P50.04)
et al,
clinical trials
227 Postoperative
swelling and
pain after
artificial knee
and CLR
Arnica 30D versus
Arnica was effective on
swelling and pain only
in the CLR trial
Seeley et al,
29 Rhytidectomy Arnica (SinEcch)
versus placebo
Patients receiving Arnica
had a smaller area of
ecchymosis on
postoperative days 1, 5,
7, and 10. These
differences were
statistically significant
only on postoperative
days 1 (P,0.005) and 7
et al,
cohort study
133 Muscoskeletal
trauma and
Traumeel versus
Complete resolution
of pain and inflammatory
symptoms at the end of
therapy were observed in
59.4% of patients in the
Traumeel group and in
57.8% of patients in the
conventional medicine
et al,
111 Tonsillectomy Arnica 30c versus
Arnica reduced pain scores
(P,0.05). No difference
was observed in
analgesia consumption,
complications, and
return to normal
activities when
comparing Arnica to
clinical study
48 Rhinoplasty Arnica (SinEcch)
plus oral
tapering dose of
prednisone or
no treatment
(control group)
Arnica and
dexamethasone reduced
swelling-edema if
compared with control
(P,0.0001). Arnica and
control group exhibited
more resolution of
ecchymosis if compared
with dexamethasone
Widrig et al,
204 Hand
Arnica gel versus
ibuprofen gel
Arnica and ibuprofen
were equally effective
for the treatment of
hand osteoarthritis as
(Continued on next page)
Effectiveness and Safety of Arnica montana e189 American Journal of Therapeutics (2016) 23(1)
Copyright © 201 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Table 1. (Continued) Clinical efficacy of Arnica montana.
year Design No. Patients Pathology Treatment Outcome Homeopathy
far as pain reduction,
hand function, number
of painful joints in both
hands and intensity of
morning stiffness in the
worst affected hand
were concerned
Paris et al,
A phase 3
158 Knee ligament
Arnica 5c,
Bryonia alba 5c,
perforatum 5c,
and Ruta
graveolens 3D
versus placebo
or no treatment
Homeopathic treatment
was not superior to
morphine consumption
after knee ligament
reconstruction. No
significant difference in
pain assessed by visual
analog scale was
observed between
Arnica and placebo
Karow et al,
group study
88 Hallux valgus
Arnica 4D versus
Arnica and diclofenac had
equivalent efficacy on
wound irritation,
patient mobility, and
use of analgesics.
Diclofenac was more
effective in reducing
pain if compared with
Arnica (P50.027)
et al,
53 Leg pain after
calf raises
Arnica cream
versus placebo
Arnica increased pain
scores if compared with
placebo (P,0.005). No
difference in muscle
tenderness and ankle
motion was observed
Cornu et al,
parallel trial
90 Aortic valve
A combination of
Arnica montana
5c and Bryonia
alba 5c granules
versus placebo
No difference between
homeopathic treatment
and placebo on
bleeding, C-reactive
protein, troponin I, and
cumulated morphine
was observed
Leu et al,
16 595-nm pulsed-
dye laser-
bruises on the
bilateral upper
inner arms
5% vitamin K
versus 1%
vitamin K and
0.3% retinol or
5% vitamin K or
20% Arnica or
white petrolatum
The mean improvement in
bruising associated
with 20% Arnica was
greater than with white
petrolatum (P50.003),
and the mixture of 1%
vitamin K and 0.3%
retinol (P50.01) while
improvement with
Arnica was not greater
than with 5% vitamin K
Huber et al,
2 Erbium YAG-
grade-2 burns
Combudoron gel
liquid or placebo
Eschars treated with
Combudoron fell off
earlier if compared with
(Continued on next page)
e190 Iannitti et al
American Journal of Therapeutics (2016) 23(1)
Copyright © 201 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
7 days) was tested on erbium YAG laserinduced
grade 2 burns. This single-blind randomized study
involved 2 healthy male subjects receiving treatment
or placebo on their backs at 4 sites. After 1 week of
treatment, the diameters of the lesions were only
slightly different between treatments. Most notably,
the eschars treated with Combudoron fell off earlier
than the placebo suggesting that Combudoron has
In a randomized,
double-blind 2-week study, twice a day topical appli-
cation of Arnica 13gel on one side of the face, before or
after laser treatment was compared with vehicle appli-
cation on the other hemiface in 19 patients affected by
facial telangiectasias without improvement in visual ana-
log scale (VAS) bruising.
Contrasting results were ob-
tained in a 2-week double-blind randomized study
including 16 healthy patients who underwent creation
of 7-mm standard bruises on the upper inner arms by
a 595-nm pulsed-dye laser.
Comparison of VAS-
bruising scores indicated that 20% Arnica gel reduced
bruising when compared with placebo and gel contain-
ing 1% vitamin K and 0.3% retinol, whereas comparison
with 5% vitamin K gel did not show any significant
In a randomized, double-blind 3-week study which
involved 204 patients affected by osteoarthritis of
interphalangeal joints of the hands, topical application
of a 4-cm gel strip of Arnica (50 g tincture/100 g) 3
times a day showed similar efficacy to ibuprofen
(5%) gel in reducing pain, functional capacity of the
hand, number of painful joints in both hands and
intensity of morning stiffness in the worst affected
Orally administered homeopathic formulations
Homeopathic formulations of Arnica have been
largely used in the clinical setting for the manage-
ment of knee surgery, carpal tunnel syndrome,
symptoms associated with wisdom teeth removal,
rhytidectomy, rhinoplasty, abdominal hysterectomy,
tonsillectomy, hallux valgus surgery, venous sur-
gery, hemarthrosis, aortic valve surgery, prolonged
venous perfusion, muscular pain, dental neuralgia,
and ankle sprains.
Knee surgery
Brinkhaus et al
tested the efficacy of oral adminis-
tration of Arnica 30D administered as supplement to
ordinary treatment (1 35 globules 2 hours before
surgery plus 3 35 globules at 3-hour intervals post-
operatively the day of surgery plus 3 35 globules
until the last follow-up) on postoperative swelling
and pain in patients undergoing different types of
knee surgery in 3 consecutive randomized placebo-
controlled clinical studies. Arnica reduced swelling
and pain after cruciate ligament reconstruction (57
patients; last follow-up at day 8), but not after
arthroscopy (227 patients; last follow-up at day 2),
artificial knee joint implantation (35 patients; last
follow-up at day 11), and cruciate ligament recon-
struction (57 patients; last follow-up at day 8).
Homeopathic treatment containing Arnica 5c, Bryo-
nia Alba 5c, Hypericum perforatum 5c, and Ruta grave-
olens 3D (4-day treatment starting 1 day before the
surgery; 5 granules per day) was not superior to
placebo in reducing 24-hour morphine consumption
after knee ligament reconstruction in a randomized
controlled study including 158 patients.
Table 1. (Continued) Clinical efficacy of Arnica montana.
year Design No. Patients Pathology Treatment Outcome Homeopathy
gel or placebo
Kucera et al,
570 Acute ankle joint
Combination of
Arnica tincture
and HES (spray)
versus Arnica or
HES or placebo
On day 3–4, improvement in
pain on active motion was
significantly higher in the
Arnica + HES group if
compared with the other 3
groups (t-test with
unadjusted baseline
values, P,4310
and ANCOVA after
adjustment, P,5310
CLR, cruciate ligament reconstruction; HES, hydroxyethyl salicylate.
Effectiveness and Safety of Arnica montana e191 American Journal of Therapeutics (2016) 23(1)
Copyright © 201 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Carpal tunnel syndrome
In a double-blind randomized trial involving 62 pa-
tients, Arnica 30c or 6c administered daily from 7
days before to 14 days after surgery (3 tablets) was
not effective in reducing bruising, swelling, and pain
in patients undergoing elective surgery for carpal
tunnel syndrome.
Wisdom teeth removal
In a double-blind trial, Arnica 200c administered to 39
patients undergoing the removal of impacted wisdom
teeth, was less effective for pain and swelling manage-
ment compared with placebo or metronidazole.
Arnica was also less effective in promoting healing
when compared with metronidazole.
In a random-
ized double-blind placebo-controlled crossover trial
including 24 patients undergoing prophylactic surgical
removal of identical bilaterally impacted mandibular
third molars, homeopathic treatment (30D) containing
and Plantago did not produce any improvement in
VAS pain score, postoperative bleeding and swelling
and side effect profile when compared with the control
Table 2. Studies on Arnica montana side effect profile.
Author(s), year Formulation Pathology Side effect profile Dose
Knuesel et al,
Gel (topical
Knee osteoarthritis One allergic reaction
(not specified)
Stevinson et al,
Tablets (oral
Hand surgery (carpal
tunnel syndrome)
Dry mouth Arnica 6c (for drowsiness
and sore tongue)
Headache Arnica 30c (for dry mouth,
headache, and feeling
Feeling “throbby” in
Sore tongue
Widrig et al,
Gel (topical
Hand osteoarthritis Skin irritations
Allergic eczema
Increased finger pain
Karow et al,
Pills (oral
Hallux valgus surgery Abdominal complaints Arnica 4D
Racing heart
Cornu et al,
Granules (oral
Aortic valve surgery Cardiovascular events
(observed in both
homeopathy and
placebo groups)
Arnica 5c and Bryonia
alba 5c
Kucera et al,
Spray (topical
Ankle distortion Burning, reddening,
itching and urticaria
were observed in the
group receiving Arnica
and hydroxyethyl
salicylate. No adverse
reactions were observed
in patients receiving
Arnica alone.
Arnica tincture: 41.5 mg
Hydroxyethyl salicylate:
12.5 mg
NS, not specified in the article.
e192 Iannitti et al
American Journal of Therapeutics (2016) 23(1)
Copyright © 201 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Furthermore, a 33% less reduction in the abil-
ity to open the mouth was observed on day 3 after
homeopathic treatment with Arnica. Ernst
this study, arguing that the doses were fixed and the
treatment schedule was not as flexible as homeopathy
Arnica (SinEcch, Alpine Pharmaceuticals, San
Raphael, California; 1 dose every 8 hours for 4 days
starting from the day of surgery) was used in patients
undergoing rhytidectomy to evaluate its efficacy on
bruising caused by facelift in a prospective random-
ized double-blind study including 29 patients.
reduction in ecchymosis was observed at postopera-
tive days 1 and 7 compared with placebo, as assessed
by computer-measured skin color changes.
In a randomized double-blind clinical study involv-
ing 48 primary rhinoplasty patients, oral Arnica
(SinEcch) administered 3 times a day for 4 days
and 10 mg intravenous dexamethasone administered
intraoperatively and followed by a 6-day oral taper-
ing dose of methyl-prednisone significantly reduced
edema rating, but not intensity and extent of ecchy-
mosis at day 2 post-rhinoplasty when compared with
the control group. At postoperative day 8, Arnica and
control group showed significantly less extent and
intensity of ecchymosis when compared with dexa-
methasone group. Furthermore, no differences in
edema rating were observed among groups at this
time point.
Abdominal hysterectomy
Negative results concerning the effect of Arnica 30c
(2 doses preoperatively plus 3 doses postoperatively
for 5 days) on pain, analgesia, infection, and postop-
erative recovery were obtained in a study including
73 women who underwent total abdominal
Arnica was tested in patients undergoing tonsillec-
tomy. One hundred eleven patients undergoing tonsil-
lectomy were randomized in a double-blind fashion to
receive either Arnica 30c or placebo (2 tablets for 6
times in the first postoperative day followed by 2 tab-
lets twice a day for 7 days).
Follow-up over 14 days
after surgery showed a significant reduction in the
VAS pain scores, whereas no difference was observed
in analgesic consumption, complications and return to
normal activities.
Hallux valgus surgery
Arnica 4D (pills; postoperatively 3 times a day for 4
days) was compared with diclofenac sodium 50 mg
(postoperatively 3 times a day for 4 days) in a random-
ized double-blind clinical study in 88 patients under-
going hallux valgus surgery.
Arnica 4D and
diclofenac sodium had equivalent efficacy on wound
irritation, patient mobility, and use of analgesics,
whereas Arnica was inferior to diclofenac sodium as
far as VAS pain score was concerned.
Venous surgery
Arnica 5c, administered sublingually the night before
and immediately after saphenous surgery, did not
reduce postoperative hematomas, as evaluated 6 days
postoperatively in a randomized, prospective, multi-
centric double-blind trial involving 130 patients.
Aortic valve surgery
Negative results were reported in a double-blind clinical
study involving 90 patients undergoing aortic valve sur-
gery assessing the efficacy of a combination of Arnica 5c
and Bryonia Alba 5c.
Five homeopathic granules
administered twice a day for 5 days, starting the even-
ing before surgery for 5 days, did not produce any sig-
nificant change in the volume of blood/liquid in the
drains at their removal and postoperative blood/liquid
losses at 12 and 24 hours as well as C-reactive protein,
pain, temperature, and plasma troponin Ic.
Prolonged venous perfusion
In a double-blind, placebo-controlled clinical study
involving patients undergoing prolonged venous per-
fusion, Arnica 5c reduced pain symptoms, hyperemia,
edema, formation of hematomas and improved blood
flow, as measured by Doppler flowmetry. Arnica treat-
ment also slightly increased a number of coagulation
factors and platelet aggregation.
Muscular pain
In a double-blind randomized study involving 82
marathon runners, 5 pills of Arnica 30D, given twice
a day from the evening before until 3 days after the
marathon, improved muscle soreness measured by
VAS immediately after the competition, but it did
not protect from cell damage (creatine kinase, aspar-
tate aminotransferase, alanine aminotransferase,
lactate dehydrogenase, sodium, potassium, magne-
sium, and creatinine were analyzed) measured by
Effectiveness and Safety of Arnica montana e193 American Journal of Therapeutics (2016) 23(1)
Copyright © 201 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
muscular enzymatic reaction.
Contrasting results
were reported in another double-blind randomized
clinical study showing that Arnica 30D did not reduce
muscle soreness after long-distance running in 519
runners, as assessed by VAS and Linkert scale.
a randomized double-blind trial including 53 patients,
Arnica cream applied immediately after performing
calf raises and 2448 hours post-exercise also failed to
improve leg pain, motion, and muscle tenderness when
compared with placebo.
Dental neuralgia
Arnica was effective for treatment of dental neuralgic
pain after tooth extraction
in a placebo-controlled
randomized clinical trial. Arnica 7c (4 granules) and
Hypericum 15c (St Johns wort; 4 granules) prescribed
alternately at 4-hour intervals for 2 days, starting
immediately after clinical examinations, resulted in
pain relief experienced by 76% of patients treated with
homeopathic combination therapy versus 40% of pa-
tients treated with placebo.
Ankle sprains
Arnica tincture spray (41.5 mg) was also tested in com-
bination with hydroxyethyl salicylate (HES; 12.5 mg)
and compared with Arnica (41.5 mg), HES (12.5 mg),
and placebo for treatment of ankle joint distortion-
related pain in a prospective, randomized, double-
blind, 4-arm parallel group phase 4 study including
570 patients.
Application of Arnica plus HES 45times
daily improved pain assessed by VAS after quickly
walking a distance of approximately10monday34.
In summary, this study suggests that Arnica can act syn-
ergistically with other medications such as HES to
reduce sprained ankle joint distortion-related pain.
Although the use of homeopathic medicines is growing,
these compounds are often deemed safe and risk-free
with patients not declaring their use to their general prac-
titioner. Little evidence is available concerning the use of
Arnica in pediatric patients. In this regard, herbal prod-
ucts are extensively used to treat children without con-
sulting the pediatrician and without reporting their use
before a surgical procedure, as showed in a study by
Crowe and Lyons.
In this study, the parents of 601
children undergoing ambulatory surgery were asked to
fill in a questionnaire about the administration of herbal
medicines to their children. Sixty-six percent of children
were taking herbal medicines (Arnica and Echinacea were
most commonly used) or had taken them in the past, and
84.7% of parents had not told the practitioner about their
use, without thinking that herbal products could lead to
adverse effects and interact with anesthetic drugs and the
surgical procedure itself. These observations confirm that
homeopathic drugs may be used safely either in general
practice or on self-prescription, although the general
practitioner should be informed to avoid a delay in the
choice of a classic drug treatment, if required. Further
evidence shows that Arnica can be used for external
and internal bruising of both mother and newborn
Furthermore, Arnica has been extensively used
for soft-tissue bruising in a cohort of patients from birth
to 8.5 years of age [Avon Longitudinal Study of Parents
and Children (ALSPAC)].
A further study involving
6323 babies showed efficacy and safety of Arnica Echina-
cea powder in the detachment of the umbilical cord
(detachment times: 2 days in 5.12%, 3 days in 44.23%,
4 days in 39.74%, 5 days in 3.20%, 6 days in 3.84%, 7 and
8 days in 1.92%, and 9 days in 0.64%) recommending its
use as routine procedure in all nurseries.
As far as safety and adverse events in the adult
population are concerned, Arnica administered topi-
cally is generally well tolerated, particularly as gel for-
Only 1 allergic reaction was reported by
Knuesel et al
after topical application of Arnica for
the treatment of mild-to-moderate knee osteoarthritis.
Widrig et al
reported side effects occurring only in 5
out of 89 patients receiving Arnica gel for the treatment
of hand osteoarthritis. A further clinical trial of topical
Arnica gel treatment for laser-induced bruises did not
report any adverse reactions.
Another report evalu-
ated the irritating and sensitizing potential of Arnica
on 22 subjects without observing any adverse effects.
When administered orally, Arnica is safe and well
tolerated only at very low concentrations, such as
those used in homeopathic medicines.
Arnicasgood tolerability and efficacy proved that
Arnica in gel formulation, as well as in homeopathic
dilutions for oral use, is an important therapeutic
agent which can be used for pain relief, post-
traumatic edema, and in the postoperative setting.
Furthermore, in certain cases, such as local and gener-
alized pain, the simultaneous administration of topical
and orally administered Arnica, besides being safe and
well tolerated, is indicated
because of the therapeutic
synergy created between the two administration
routes. We have summarized the studies reporting
on Arnica side effect profile in Table 2.
Over the past twenty years, the use of homeopathic
medicines has increased worldwide in terms of both
e194 Iannitti et al
American Journal of Therapeutics (2016) 23(1)
Copyright © 201 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
prescriptions by physicians and increased recommen-
dation by pharmacists. In particular, Arnica is one of
the homeopathic remedies used for over 100 years for
the treatment of trauma-associated pain and swelling.
This review summarizes the available preclinical and
clinical evidence concerning the efficacy and safety of
the homeopathic product Arnica in pain-related pro-
cesses. Overall, Arnica (topical and/or oral formula-
tions) has demonstrated reproducible clinical
benefits, some of which are comparable with anti-
inflammatory drugs such as diclofenac,
and corticosteroids
which are considered
the therapeutics of choice for the treatment of osteoar-
thritis, postoperative edema, and ecchymosis.
Although limited evidence is available for the use of
Arnica in the context of wound healing, a study sug-
gests that it can be used instead of diclofenac after
hallux valgus surgery to reduce wound irritation and
at a lower cost.
Furthermore, combined with stinging
nettle, it showed promising results in 2 patients with
grade 2 laser-induced burns.
In patients undergoing
the removal of impacted wisdom teeth, Arnica was less
effective for the management of pain and swelling
compared with placebo suggesting that it should not
be used in that clinical condition.
These findings sug-
gest that Arnica can be used in the context of wound
healing in selected clinical scenarios. However, the
limited number of studies warrants further investiga-
tions. The topical use of Arnica is supported by studies
evincing its efficacy in relieving acute muscle pain
after excessive exercise,
and in the symptomatic
treatment of osteoarthritis.
The local action is ex-
erted: (1) at the level of the locomotor system on the
muscles, calming the feeling of soreness and pain
; (2)
in the joints, reducing the swelling and pain caused by
rheumatic disorders; (3) in the capillaries and veins,
reducing hematoma and ecchymosis and protecting
blood vessels.
Additionally, Arnica administered
orally in homeopathic dilutions showed positive clin-
ical effects in reducing postoperative pain, swelling,
edema, and ecchymosis.
Furthermore, topical
Arnica combined with oral homeopathic dilutions sig-
nificantly reduced postoperative pain.
As to topical
gels, this review points out that Arnica has clinical
benefits in relieving pain and surgical complications.
The topical application of Arnica thus offers an alter-
native to ibuprofen because of the high concentration
of sesquiterpenes,
and in particular helenalin, which
is the active substance held responsible for its anti-
inflammatory activity.
The level of sesquiterpenes
depends on multiple factors. For example, Douglas
et al
showed that the total amount of bioactive
endogenous sesquiterpenes varies depending on
which portion of the plant is being used. The
concentration of sesquiterpenes was found to be
higher in the disc florets than in the ray florets, lower
in the receptacle, and even lower in the stalk.
variability in the quantity of sesquiterpenes, with
a consequent variation in the biological activity, can
influence the clinical efficacy of Arnica.
To guarantee
the efficacy of medicines containing Arnica,itisneces-
sary to obtain a phytocomplex with optimal levels of
active substances. This requires the use of high-quality
raw material that is obtained by harvesting whole, fresh
and spontaneously occurring Arnica in its natural hab-
itat, far from any form of pollution and during the bal-
samic phase. Reproducibility is assured by accurate
botanical identification, safeguarding the freshness of
the batch, and performing checks on the raw material
and the finished product. The quality and safety of
homeopathic medicines containing Arnica are guaran-
teed by the European Pharmacopoeia and by specific
Arnica monographs included in the pharmacopoeias of
the individual member states. Pharmaceutical compa-
nies which produce homeopathic medicines containing
Arnica in compliance with these standards are able to
guarantee its efficacy and safety. Specifically, Arnica use
in various clinical settings is achieving a wider reputa-
tion supported by an arising number of open studies,
even if comparison of this compound with traditional
drugs has been rarely performed.
Cumulative evidence suggests that both Arnica in gel
formulation and in homeopathic dilutions are more
effective than placebo in treating several inflamma-
tory conditions, in pain management and postopera-
tive settings. Its clinical efficacy in these fields and its
high tolerability make it a potential therapeutic alter-
native target to non-steroidal anti-inflammatory
drugs, especially for patients undergoing pharmaco-
logical polytherapy as they are more exposed to the
risk of drug interactions and, consequently, to their
toxicity. The wide variability of formulations and
therapeutic settings precludes a meta-analysis that
could assess the efficacy of specific protocols. Further
trials involving larger cohorts of patients are needed
to support a possible effect of Arnica in several
inflammatory conditions, in pain management and
postoperative settings.
JCMM acknowledges CONACyT-Mexico for its
Effectiveness and Safety of Arnica montana e195 American Journal of Therapeutics (2016) 23(1)
Copyright © 201 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
1. WHO. Safety Issues in the Preparation of Homeopathic Med-
icines. Geneva, Switzerland: World Health Organization
documents; 2009. Available at:
2. Paris A, Gonnet N, Chaussard C, et al. Effect of homeop-
athy on analgesic intake following knee ligament recon-
struction: a phase III monocentre randomized placebo
controlled study. Br J Clin Pharmacol. 2008;65:180187.
3. Stevinson C, Devaraj VS, Fountain-Barber A, et al.
Homeopathic arnica for prevention of pain and bruising:
randomized placebo-controlled trial in hand surgery. JR
Soc Med. 2003;96:6065.
4. Bellavite P, Marzotto M, Olioso D, et al. High-dilution
effects revisited. 1. Physiochemical aspects. Homeopathy.
5. Bellavite P, Marzotto M, Olioso D, et al. High-dilution
effects revisited. 2. Pharmacodynamic mechanisms. Home-
opathy. 2014;103:2243.
6. Bell IR, Koithan M. A model for homeopathic remedy ef-
fects: low dose nanoparticles, allostatic cross-adaptation,
and time-dependent sensitization in a complex adaptive
system. BMC Complement Altern Med. 2012;12:191.
7. Roy R, Tiller W, Bell IR, et al. The structure of liquid
water. Novel insights from materials research; potential
relevance to homeopathy. Mat Res Innovat. 2005;9:98103.
8. Jeschke E, Ostermann T, Luke C, et al. Remedies contain-
ing Asteraceae extracts: a prospective observational
study of prescribing patterns and adverse drug reactions
in German primary care. Drug Saf. 2009;32:691706.
9. Obon C, Rivera D, Verde A, et al. Arnica: a multivariate
analysis of the botany and ethnopharmacology of
a medicinal plant complex in the Iberian Peninsula and
the Balearic Islands. J Ethnopharmacol. 2012;144:4456.
10. Lawrence WT. Arnica. Plast Reconstr Surg. 2003;112:
11. Alonso D, Lazarus MC, Baumann L. Effects of topical
arnica gel on post-laser treatment bruises. Dermatol Surg.
12. Widrig R, Suter A, Saller R, et al. Choosing between
NSAID and arnica for topical treatment of hand osteoar-
thritis in a randomised, double-blind study. Rheumatol
Int. 2007;27:585591.
13. Alvarez-Hernandez E, Cesar Casasola-Vargas J, Lino-
Perez L, et al. Complementary and alternative medicine
in patients attending a rheumatology department for the
first time. Analysis of 800 patients. Reumatol Clin. 2006;2:
14. Lyss G, Schmidt TJ, Merfort I, et al. Helenalin, an anti-
inflammatory sesquiterpene lactone from Arnica, selec-
tively inhibits transcription factor NF-kappaB. Biol Chem.
15. Hall IH, Starnes CO Jr, Lee KH, et al. Mode of action of
sesquiterpene lactones as anti-inflammatory agents.
J Pharm Sci. 1980;69:537543.
16. Tornhamre S, Schmidt TJ, Nasman-Glaser B, et al.
Inhibitory effects of helenalin and related compounds
on 5-lipoxygenase and leukotriene C(4) synthase in human
blood cells. Biochem Pharmacol. 2001;62:903911.
17. Berges C, Fuchs D, Opelz G, et al. Helenalin suppresses
essential immune functions of activated CD4+ T cells by
multiple mechanisms. Mol Immunol. 2009;46:28922901.
18. Baeuerle PA, Henkel T. Function and activation of NF-
kappa B in the immune system. Annu Rev Immunol. 1994;
19. Lawrence T, Gilroy DW, Colville-Nash PR, et al. Possible
new role for NF-kappaB in the resolution of inflamma-
tion. Nat Med. 2001;7:12911297.
20. Klaas CA, Wagner G, Laufer S, et al. Studies on the anti-
inflammatory activity of phytopharmaceuticals prepared
from Arnica flowers. Planta Med. 2002;68:385391.
21. Verma N, Tripathi SK, Sahu D, et al. Evaluation of inhib-
itory activities of plant extracts on production of LPS-
stimulated pro-inflammatory mediators in J774 murine
macrophages. Mol Cell Biochem. 2010;336:127135.
22. de Camargo RA, da Costa ED, Catisti R. Effect of the oral
administration homeopathic Arnica montana on mito-
chondrial oxidative stress. Homeopathy. 2013;102:4953.
23. Conforti A, Bellavite P, Bertani S, et al. Rat models of
acute inflammation: a randomized controlled study on
the effects of homeopathic remedies. BMC Complement
Altern Med. 2007;7:1.
24. Kawakami AP, Sato C, Cardoso TN, et al. Inflammatory
process modulation by homeopathic arnica montana
6CH: the role of individual variation. Evid Based Comple-
ment Alternat Med. 2011;2011:917541.
25. Macedo SB, Ferreira LR, Perazzo FF, et al. Anti-inflammatory
activity of Arnica montana 6cH: preclinical study in animals.
Homeopathy. 2004;93:8487.
26. Lussignoli S, Bertani S, Metelmann H, et al. Effect of
Traumeel S, a homeopathic formulation, on blood-
induced inflammation in rats. Complement Ther Med.
27. Hall IH, Lee KH, Starnes CO, et al. Anti-inflammatory
activity of sesquiterpene lactones and related com-
pounds. J Pharm Sci. 1979;68:537542.
28. Castro FC, Magre A, Cherpinski R, et al. Effects of micro-
current application alone or in combination with topical
Hypericum perforatum L. and Arnica montana L. on
surgically induced wound healing in Wistar rats. Home-
opathy. 2012;101:147153.
29. Kaziro GS. Metronidazole (Flagyl) and Arnica montana
in the prevention of post-surgical complications, a com-
parative placebo controlled clinical trial. Br J Oral Max-
illofac Surg. 1984;22:4249.
30. Albertini H, Goldberg W. Evaluation dun traitement
eopathique de le n
evralgie dentaire. Bilan de 60 observa-
tions dentaires in recherches en hom
eopathie. Lyon, France:
Fondat. Franc. Rech. Hom
eopath; 1986:75.
31. Zell J, Connert WD, Mau J, et al. Treatment of acute
sprains of the ankle joint. Double-blind study assessing
the effectiveness of a homeopathic ointment preparation.
Fortschr Med. 1988;106:96100.
32. Dorfman P, Amodeo C, Ricciotti F, et al. Évaluation de
edelArnica 5CH sur les troubles veineux après
e196 Iannitti et al
American Journal of Therapeutics (2016) 23(1)
Copyright © 201 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
perfusion prolong
ee. Cahiers de Bioth
erapie 1988;98
33. Baillargeon L, Drouin J, Desjardins L, et al. The effects of
Arnica montana on blood coagulation. Randomized con-
trolled trial. Can Fam Physician. 1993;39:23622367.
34. Lokken P, Straumsheim PA, Tveiten D, et al. Effect of
homoeopathy on pain and other events after acute
trauma: placebo controlled trial with bilateral oral sur-
gery. BMJ. 1995;310:14391442.
35. Hart O, Mullee MA, Lewith G, et al. Double-blind, placebo-
controlled, randomized clinical trial of homoeopathic arnica
C30 for pain and infection after total abdominal hysterec-
tomy. JRSocMed.1997;90:7378.
36. Vickers AJ, Fisher P, Smith C, et al. Homeopathic Arnica
30x is ineffective for muscle soreness after long-distance
running: a randomized, double-blind, placebo-controlled
trial. Clin J Pain. 1998;14:227231.
37. Ramelet AA, Buchheim G, Lorenz P, et al. Homeopathic
Arnica in postoperative haematomas: a double-blind
study. Dermatology. 2000;201:347348.
38. Jeffrey SL, Belcher HJ. Use of Arnica to relieve pain after
carpal-tunnel release surgery. Altern Ther Health Med.
39. Knuesel O, Weber M, Suter A. Arnica montana gel in
osteoarthritis of the knee: an open, multicenter clinical
trial. Adv Ther. 2002;19:209218.
40. Wolf M, Tamaschke C, Mayer W, et al. Efficacy of Arnica
in varicose vein surgery: results of a randomized,
double-blind, placebo-controlled pilot study. Forsch Kom-
plementarmed klass Naturheilkd. 2003;10:242247.
41. Tveiten D, Bruset S. Effect of Arnica D30 in marathon
runners. Pooled results from two double-blind placebo
controlled studies. Homeopathy. 2003;92:187189.
42. Brinkhaus B, Wilkens JM, Ludtke R, et al. Homeopathic
arnica therapy in patients receiving knee surgery: results
of three randomised double-blind trials. Complement Ther
Med. 2006;14:237246.
43. Seeley BM, Denton AB, Ahn MS, et al. Effect of homeo-
pathic Arnica montana on bruising in face-lifts: results of
a randomized, double-blind, placebo-controlled clinical
trial. Arch Facial Plast Surg. 2006;8:5459.
44. Schneider C, Schnieder B, Hanisch J, et al. The role of
a homeopathic preparation compared with conventional
therapy in the treatment of injuries: an observational
cohort study. Complement Ther Med. 2008;16:2227.
45. Ernst E. Effects of homoeopathy. Trial did not evaluate
truehomoeopathy. BMJ. 1995;311:510511.
46. Adkison JD, Bauer DW, Chang T. The effect of topical
arnica on muscle pain. Ann Pharmacother. 2010;44:
47. Cornu C, Joseph P, Gaillard S, et al. No effect of a homoe-
opathic combination of Arnica montana and Bryonia al-
ba on bleeding, inflammation, and ischaemia after aortic
valve surgery. Br J Clin Pharmacol. 2010;69:136142.
48. Leu S, Havey J, White LE, et al. Accelerated resolution of
laser-induced bruising with topical 20% arnica: a rater-
blinded randomized controlled trial. Br J Dermatol. 2010;
49. Huber R, Bross F, Schempp C, et al. Arnica and stinging
nettle for treating burns - a self-experiment. Complement
Ther Med. 2011;19:276280.
50. Kucera M, Kolar P, Barna M, et al. Arnica/Hydroxyethyl
salicylate combination spray for ankle distortion: a four-
arm randomised double-blind study. Pain Res Treat.
51. Totonchi A, Guyuron B. A randomized, controlled com-
parison between arnica and steroids in the management
of postrhinoplasty ecchymosis and edema. Plast Reconstr
Surg. 2007;120:271274.
52. Robertson A, Suryanarayanan R, Banerjee A. Homeo-
pathic Arnica montana for post-tonsillectomy analgesia:
a randomised placebo control trial. Homeopathy. 2007;96:
53. Karow JH, Abt HP, Frohling M, et al. Efficacy of Arnica
montana D4 for healing of wounds after Hallux valgus
surgery compared to diclofenac. J Altern Complement
Med. 2008;14:1725.
54. Crowe S, Lyons B. Herbal medicine use by children pre-
senting for ambulatory anesthesia and surgery. Paediatr
Anaesth. 2004;14:916919.
55. Kaplan B. Homoeopathy: 2. In pregnancy and for the
under-fives. Prof Care Mother Child. 1994;4:185187.
56. Thompson EA, Bishop JL, Northstone K. The use of
homeopathic products in childhood: data generated over
8.5 years from the Avon Longitudinal Study of Parents
and Children (ALSPAC). J Altern Complement Med. 2010;
57. Perrone S, Coppi S, Coviello C, et al. Efficacy of Arnica
Echinacea powder in umbilical cord care in a large
cohort study. J Matern Fetal Neonatal Med. 2012;25:1111
58. Final report on the safety assessment of Arnica montana
extract and Arnica montana. Int J Toxicol. 2001;20
(Suppl 2):111.
59. DerMarderosian A, Beutler JA, eds. Facts and Compari-
sons: The Review of Natural Products. St. Louis, MO: Wol-
ters Kluwer; 2001.
60. Ross SM. Osteoarthritis: a proprietary Arnica gel is
found to be as effective as ibuprofen gel in osteoarthritis
of the hands. Holist Nurs Pract. 2008;22:237239.
61. Moore RA, Tramer MR, Carroll D, et al. Quantitative
systematic review of topically applied non-steroidal
anti-inflammatory drugs. BMJ. 1998;316:333338.
62. Schmidt C. A double-blind, placebo-controlled trial:
arnica montana applied topically to Subcutaneous
mechanical Injuries. J Am Inst Homeopathy. 1996;89:186.
63. Merfort I. Arnica: new insights on the molecular mode of
action of a traditional medicinal plant. Forsch Komplemen-
tarmed klass Naturheilkd. 2003;10(Suppl 1):4548.
64. Douglas JA, Smallfield BM, Burgess EJ, et al. Sesquiter-
pene lactones in Arnica montana: a rapid analytical
method and the effects of flower maturity and simulated
mechanical harvesting on quality and yield. Planta Med.
Effectiveness and Safety of Arnica montana e197 American Journal of Therapeutics (2016) 23(1)
Copyright © 201 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
... 11,12 Arnica has been used in cases of bruises and inflammation for pain management and healing of wounds. 13 Many homeopathic medications such Belladonna, Chamomilla, Coffea Cruda, Hepar sulph, Arnica, and Plantago have been used in dentistry. 14 Arnica and Hypericum have been used for pain management in dentistry. ...
... Homeopathy as an alternative branch of medicine has been steadily growing in India and Arnica and Hypericum has been used as the most common agents for pain management. 13,15 Pain associated with dental extraction is due to inflammation and hence Arnica is better-suited postextraction than Hypericum. 21 Pain may be regarded as the proxy measure for inflammation following dental extraction. ...
Aim: To compare the homeopathic drug Arnica with ibuprofen as an analgesic for postextraction pain control in children. Materials and methods: Forty-four healthy children between 8 and 12 years of age requiring two clinical sessions of tooth extraction in two different quadrants of the oral cavity were selected for the study. All the children received both the drugs in this crossover trial with a washout of 10 days. Patient-rated and operator-assessed pain was compared to a 10-point validated Visual Analog Scale at baseline, 24, 48, and 72 hours using the paired t-test. Acceptance to taste and frequency of dosing was recorded at the end of three days using a five-point Likert scale and were compared using the Chi-squared test. Kappa statistics were performed to assess intraoperator variability. Results: Pain reduction by Ibuprofen was significantly more than Arnica only at 48 hours with respect to both patient-reported and operator-assessed pain [(t = 3.567, p < 0.05), (t = 2.834, p < 0.05)]. As the age of the child increased, patient-reported pain significantly decreased. Children preferred the taste of Arnica over that of Ibuprofen (x 2 = 56.76, p < 0.0001). Conclusion: There was no difference between Arnica and Ibuprofen in the postextraction pain management in 8-12-year-old children. Clinical significance: The results of this study suggest that Arnica may be considered as an alternative to ibuprofen in managing postextraction pain in 8-12-year-old children, especially those with asthma, COPD, or known allergy to ibuprofen. How to cite this article: Thakur JH, Katre AN. Comparison of the Efficacy of Homeopathic Drug Arnica and Ibuprofen on Postextraction Pain in Children: A Triple-blind Randomized Controlled Trial. Int J Clin Pediatr Dent 2022;15(3):332-337.
... Результатами исследования стали выводы о том, что арника (формы для наружного и/ или перорального применения) продемонстрировала воспроизводимые положительные клинические результаты и некоторые из них могут быть сравнимы с действием противовоспалительных лекарственных препаратов, таких как диклофенак, ибупрофен и кортикостероиды, которые считаются предпочтительными терапевтическими средствами при лечении остеоартрита, послеоперационных отеков и экхимозов. Клиническая эффективность арники в указанных областях в сочетании с высокой переносимостью позволяет рассматривать ее как возможную терапевтическую альтернативу традиционным нестероидным противовоспалительным препаратам, особенно для пациентов, проходящих фармакологическую политерапию, поскольку они в большей степени подвержены риску нежелательных взаимодействий между лекарственными препаратами и, как следствие, их токсичности [5]. ...
... Высокий уровень безопасности совместного приема достигается за счет избирательного действия на циклооксигеназу-2 и прицельного подавления медиаторов воспаления. В результате происходят более быстрое уменьшение гематомы в размерах, снятие отечности и воспалительных явлений по сравнению с монотерапией каждой из форм [4,5]. ...
Full-text available
Background. Invasive aesthetic medicine is associated with various rehabilitation manifestations: hematomas, edema, pain after the procedure. Hematomas are an unpleasant, but often inevitable for the patient. In this case, hematomas appear when a vessel is directly injured by a needle during the procedure, which is always associated with skin trauma and an increased risk of infection. Aim. Application of an effective treatment regimen without pronounced side effects for minimizing rehabilitation phenomena after aesthetic procedures. Materials and methods. The study involved 50 patients, 25 of whom received anti hematoma therapy with external and systemic forms of Arnica montana (Boiron) before and after the procedure. 25 remaining (control group) did not receive therapy before the procedure, as well as during rehabilitation after the procedure. The analysis of the course of the rehabilitation period was assessed using a questionnaire, which contained questions on assessing the degree of intensity of such adverse events after the procedure as pain, edema, hyperemia, the size of hematomas according to a scale from 0 to 5, where 0 no manifestations, 5 significantly pronounced manifestations. Results. An analysis of many clinical cases shows the effectiveness of antihematoma therapy with Arnica montana preparations in various forms [Arnica montana C9 (Boiron) and Arnigel] before and after procedure, manifested in a faster resolution of hematomas, a decrease in edema, a decrease in pain after the procedure, as well as an overall reduction in the rehabilitation period by at least 23 days compared with the course of rehabilitation without the appointment of anti-hematoma therapy. Conclusion. Based on the above data, confirmed by numerous studies, we can conclude about the effectiveness of prescribing Arnica drugs [Arnica montana C9 (Boiron) and Arnigel] before and after invasive aesthetic procedures.
... A. montana also improve physical functions of OA patients. [111][112][113] Traditionally, the herb rosemary, scientifically known as Rosmarinus officinalis, has been used to treat conditions including asthma, dysmenorrhea, and the discomfort associated with renal colic. Anti-inflammatory, antioxidant, and anti-nociceptive benefits are all attributed to Rosemary. ...
... It has shown significant effects in reducing inflammation and hematoma. Arnica has shown its efficacy in treating osteoarthritis, myocardiopathy, arteriosclerosis, sprains, edema, and other acute inflammatory conditions [12,13]. ...
Ethnomedicines in the literature compare the therapeutic efficacy of various herbs based on active ingredients of plants and animals. The application of phytomedicines in the field of dentistry is uncommon. The main objective of this article is to access the efficacy of ethnomedicines and newly evolving treatment modalities in reducing post-op complications following dentoalveolar surgeries. Inclusion criteria were selected according to the population, intervention, control, and outcomes (PICO) format. Case reports, case series, retrospective studies, and studies with inappropriate reporting of outcomes were all excluded. An electronic search of English literature in PubMed was performed using the keywords Ethnomedicine, Anti-inflammatory, Analgesics, Therapeutic herbs, Herbal mouthwashes, Third molar surgery. A total of 25 articles were selected, of which three were on herbal mouthwashes and 22 were on anti-inflammatory effect. All the articles were regarding the therapeutic effect of the herbs. The present paper studies various traditionally used therapeutic herbs, their benefits, and shortcomings with their application in dentistry. This study has shown the different herbal alternatives to conventionally used drugs in relation to third molar.
... This effect on oxidative stress with Arnica m. dilutions that we observed could explain the anti-inflammatory properties and moreover its antiinflammatory effects as observed in clinical practice. 15 The beneficial effects of Arnica montana are well documented. The main active compound responsible for biological effects of Arnica montana is the sesquiterpene lactone helenalin. ...
Full-text available
Microglial cells play important roles in inflammatory responses. The level of oxidative stress is a well-known marker of inflammation. Homeopathic medicines are often used clinically to alleviate inflammation. We evaluated the anti-oxidative effect of high dilutions of Arnica montana (Arnica m.), Arsenicum album (Arsenicum a.), and Lachesis mutus (Lachesis m.) on production of reactive oxygen species (ROS) in inflamed microglial cells in vitro. Microglial cells, on exposure to lipopolysaccharide (LPS), have induced production of ROS compared with resting cells. The dilutions significantly reduced the oxidative stress by decreasing the level of ROS produced. Arnica m. 1C, 3C, 5C, 7C, 9C, and 30C dilutions had a range of ROS reduction between 15 and 42.1%; Arsenicum a. 3C, 5C, 7C, 15C, and 30C dilutions had a range of ROS reduction between 17.6 and 35.3%; and Lachesis m. 3C, 5C, 7C, 9C, 15C, and 30C dilutions had a range of ROS reduction between 25 and 41.7%. To summarize, the dilutions with the greatest effect were Arnica m. 1C (42.1%), Arsenicum a. 30C (35.3%), and Lachesis m. 7C (41.7%). Arnica m., Arsenicum a., and Lachesis m. did not have the same effect on ROS production and were not dose-dependent.
... As espécies vegetais comercializadas foram comparadas às descritas na RENISUS. Sombra, 2016;Martinazzo, et al., 2013;Gonçalves, et al., 2011;Parente, Rosa, 2001) (Athayde, et al., 2021;Iannitti, et al., 2016;Ahmad, et al., 2013;Borsato, et al., 2000). ...
Full-text available
Este trabalho visou realizar um levantamento etnobotânico das plantas comercializadas como medicinais e fitoterápicos no município de Resende, RJ. Para tanto, foram mapeados os principais tipos de comércio de plantas medicinais e fitoterápicos e as espécies vegetais comercializadas no município foram registradas. O uso tradicional relatado foi correlacionado com as propriedades biológicas dos metabólitos biossintetizados pelas espécies vegetais já descritas na literatura. O levantamento etnobotânico e a pesquisa acerca do uso de espécies vegetais e fitoterápicos no município revelou que 44% das espécies descritas na RENISUS são comercializadas nas feiras e ervanários visitados e, 77% dessas espécies estão entre as mais consumidas. Foi possível observar que muitas das propriedades biológicas para as quais as espécies vegetais são tradicionalmente consumidas têm correlação com os metabólitos biossintetizados e comprovação descrita na literatura. Tais resultados podem auxiliar na implementação da Política Nacional de Plantas Medicinais e Fitoterápicos no munícipio e no Sul Fluminense, além de contribuir para o acesso seguro, o uso racional e sustentável da biodiversidade.
... 60 Another study found that Arnica reduced edema but not ecchymosis after rhinoplasty and reduced ecchymosis compared with placebo after facelifting. 61 The most recent literature review by American Academy of Ophthalmology does not support the use of Arnica for reducing ecchymosis after oculoplastic surgery. 62 Tranexamic acid is an antifibrinolytic agent beginning to be studied in oculoplastic surgery 63 but has been used in trauma, orthopedic, cardiac, and recently (off-label) in plastic surgery to reduce blood loss and possibly to improve postoperative edema. ...
Full-text available
Purpose: Recent survey studies have demonstrated wide variability in practice patterns regarding the management of antithrombotic medications in oculofacial plastic surgery. Current evidence and consensus guidelines are reviewed to guide perioperative management of antithrombotic medications. Methods: Comprehensive literature review of PubMed database on perioperative use of antithrombotic medication. Results/conclusions: Perioperative antithrombotic management is largely guided by retrospective studies, consensus recommendations, and trials in other surgical fields due to the limited number of studies in oculoplastic surgery. This review summarizes evidence-based recommendations from related medical specialties and provides context for surgeons to tailor antithrombotic medication management based on patient's individual risk. The decision to continue or cease antithrombotic medications prior to surgery requires a careful understanding of risk: risk of intraoperative or postoperative bleeding versus risk of a perioperative thromboembolic event. Cessation and resumption of antithrombotic medications after surgery should always be individualized based on the patient's thrombotic risk, surgical and postoperative risk of bleeding, and the particular drugs involved, in conjunction with the prescribing doctors. In general, we recommend that high thromboembolic risk patients undergoing high bleeding risk procedures (orbital or lacrimal surgery) may stop antiplatelet agents, direct oral anticoagulants, and warfarin including bridging warfarin with low-molecular weight heparin. Low-risk patients, regardless of type of procedure performed, may stop all agents. Decision on perioperative management of antithrombotic medications should be made in conjunction with patient's internist, cardiologist, hematologist, or other involved physicians which may limit the role of guidelines depending on patient risk and should be used on a case-by-case basis. Further studies are needed to provide oculofacial-specific evidence-based guidelines.
... Arnica is used a lot for self-care (10,11) and also in midwifery (12) and surgery (13). Meanwhile, some 30 studies have been conducted where homeopathic Arnica has been applied before or after surgery to improve wound healing, stop bleeding and swelling, and reduce pain. ...
Full-text available
Background: Homeopathic Arnica montana is used in surgery as prevention or treatment for the reduction of pain and other sequelae of surgery. Our aim was to perform a metaanalysis of clinical trials to assess efficacy of Arnica montana to reduce the inflammatory response after surgery. Method: We conducted a systematic review and metaanalysis, following a predefined protocol, of all studies on the use of homeopathic Arnica montana in surgery. We included all randomized and nonrandomized studies comparing homeopathic Arnica to a placebo or to another active comparator and calculated two quantitative metaanalyses and appropriate sensitivity analyses. We used “Hegde's g,” an effect size estimator which is equivalent to a standardized mean difference corrected for small sample bias. The PROSPERO registration number is CRD42020131300. Results: Twenty-three publications reported on 29 different comparisons. One study had to be excluded because no data could be extracted, leaving 28 comparisons. Eighteen comparisons used placebo, nine comparisons an active control, and in one case Arnica was compared to no treatment. The metaanalysis of the placebo-controlled trials yielded an overall effect size of Hedge's g = 0.18 (95% confidence interval −0.007/0.373; p = 0.059). Active comparator trials yielded a highly heterogeneous significant effect size of g = 0.26. This is mainly due to the large effect size of nonrandomized studies, which converges against zero in the randomized trials. Conclusion: Homeopathic Arnica has a small effect size over and against placebo in preventing excessive hematoma and other sequelae of surgeries. The effect is comparable to that of anti-inflammatory substances.
Arnica montana, is a hemicryptophyte plant, belongs to the Asteraceae family. It is a medicinally significant herb that is used in traditional medicine systems in many countries. Flowers, roots, and rhizomes of Arnica are traditionally used for the topical treatments of various ailments such as bruises, sprains, backache, rheumatic arthritis, and phlebitis. Sesquiterpene lactones, flavonoids, fatty acids, thymol derivatives, and chlorogenic acid are the main bioactive phytochemicals. Extract and compounds from A. montana exhibited several pharmacological activities: anti-inflammatory, anticancer, antioxidant, antimicrobial, antiplatelets, and immunomodulatory activities. Helenalin and dihydrohelinalin are mainly responsible for their anti-inflammatory properties. The clinical trial using gel, cream, oil, ointment, and homeopathic dilutions revealed significant effects in relieving postoperative pains, surgical complications, swelling, edema, and ecchymosis. Different clinical trials using randomized placebo-controlled, randomized double-blinded, and open multicenter trials against different diseases reflect the medicinal importance of this plant. The aim of this chapter is to insight knowledge about the traditional uses, chemical compositions, pharmacological activities, and clinical trials of the plant Arnica montana. In vitro in in vitro.Keywords Arnica montana HomeopathySesquiterpene lactonesAnti-inflammatoryPlacebo-controlled
Introduction: Postsurgical oedema (PSE) is a common complication encountered in the dental field following different surgical procedures including wisdom teeth extraction and other periodontal and implant surgeries. Arnica Montana (AM) is a homeopathic agent which may represent as a safe, effective and an alternative agent for Non Steroidal Anti-Inflammatory (NSAID) medications to prevent or decrease the risk of PSE. Aim: To evaluate the knowledge of practicing dentists and their experiences using AM supplements in their daily practice for management of PSE. Materials and Methods: This was an observational, crosssectional self reported electronic based study to survey practicing dentists on the application of AM in daily dental practice conducted from January to September 2021. The electronic survey included 13 questions on: 1) dentist’s demographics and educational backgrounds; 2) knowledge related to AM supplement; and 3) previous experience, if any, with AM use for management of PSE. The survey was distributed to potential subjects and descriptive statistics was used to summarise the data, and presented as percentages and frequencies using Microsoft Excel for mac (Version 16.40). Results: A total of 84 subjects participated in the survey, out of which 23 (27.3%) were familiar with AM use in dentistry. Overall, 15 participants (65.2%) indicated preventions or reduction of PSE risk and pain and seven participants reported prevention and reduction of postsurgical discolouration and bleeding (30.4%) as potential indications for AM use. In total, eight participants (34.7%) have prescribed AM to patients before, mainly for external and internal sinus grafting (4/8; 50% for both) and surgical extraction of impacted teeth (2/8; 25%). Out of all, five participants (5/8; 62.5%) reported significant benefit with using AM following a surgical procedure and four participants (50%) reported numbness of the lips, altered taste sensation and increased bleeding as associated toxicities. Conclusion: From the present study the uses and user based experienced of the material AM in the field of dentistry can be well understood and analysed. This was the first survey to discuss the knowledge and application of AM among dentists from various specialties.
Full-text available
Homeopathic arnica is widely believed to control bruising, reduce swelling and promote recovery after local trauma; many patients therefore take it perioperatively. To determine whether this treatment has any effect, we conducted a double-blind, placebo-controlled, randomized trial with three parallel arms. 64 adults undergoing elective surgery for carpal tunnel syndrome were randomized to take three tablets daily of homeopathic arnica 30C or 6C or placebo for seven days before surgery and fourteen days after surgery. Primary outcome measures were pain (short form McGill Pain Questionnaire) and bruising (colour separation analysis) at four days after surgery. Secondary outcome measures were swelling (wrist circumference) and use of analgesic medication (patient diary). 62 patients could be included in the intention-to-treat analysis. There were no group differences on the primary outcome measures of pain ( P=0.79) and bruising ( P=0.45) at day four. Swelling and use of analgesic medication also did not differ between arnica and placebo groups. Adverse events were reported by 2 patients in the arnica 6C group, 3 in the placebo group and 4 in the arnica 30C group. The results of this trial do not suggest that homeopathic arnica has an advantage over placebo in reducing postoperative pain, bruising and swelling in patients undergoing elective hand surgery.
Full-text available
The principles and phenomena from materials research to study the structure of liquid water and its relevance to homeopathy were discussed. Liquid water is a nanoheterogenous statistical-mechanical distribution mainly of several molecular species including oligomers and polymers along with a minority of monomers. The structure can be easily affected by epitaxial effects, pressure during succussion, the formation of colloidal nanobubbles, and electric and magnetic fields. In homeopathy a specific active agent is added to the liquid (water or water + ethanol). The change in the internalized model is a de-emphasis on the precise possible molecules into which water may polymerize.
Full-text available
Background This paper proposes a novel model for homeopathic remedy action on living systems. Research indicates that homeopathic remedies (a) contain measurable source and silica nanoparticles heterogeneously dispersed in colloidal solution; (b) act by modulating biological function of the allostatic stress response network (c) evoke biphasic actions on living systems via organism-dependent adaptive and endogenously amplified effects; (d) improve systemic resilience. Discussion The proposed active components of homeopathic remedies are nanoparticles of source substance in water-based colloidal solution, not bulk-form drugs. Nanoparticles have unique biological and physico-chemical properties, including increased catalytic reactivity, protein and DNA adsorption, bioavailability, dose-sparing, electromagnetic, and quantum effects different from bulk-form materials. Trituration and/or liquid succussions during classical remedy preparation create “top-down” nanostructures. Plants can biosynthesize remedy-templated silica nanostructures. Nanoparticles stimulate hormesis, a beneficial low-dose adaptive response. Homeopathic remedies prescribed in low doses spaced intermittently over time act as biological signals that stimulate the organism’s allostatic biological stress response network, evoking nonlinear modulatory, self-organizing change. Potential mechanisms include time-dependent sensitization (TDS), a type of adaptive plasticity/metaplasticity involving progressive amplification of host responses, which reverse direction and oscillate at physiological limits. To mobilize hormesis and TDS, the remedy must be appraised as a salient, but low level, novel threat, stressor, or homeostatic disruption for the whole organism. Silica nanoparticles adsorb remedy source and amplify effects. Properly-timed remedy dosing elicits disease-primed compensatory reversal in direction of maladaptive dynamics of the allostatic network, thus promoting resilience and recovery from disease. Summary Homeopathic remedies are proposed as source nanoparticles that mobilize hormesis and time-dependent sensitization via non-pharmacological effects on specific biological adaptive and amplification mechanisms. The nanoparticle nature of remedies would distinguish them from conventional bulk drugs in structure, morphology, and functional properties. Outcomes would depend upon the ability of the organism to respond to the remedy as a novel stressor or heterotypic biological threat, initiating reversals of cumulative, cross-adapted biological maladaptations underlying disease in the allostatic stress response network. Systemic resilience would improve. This model provides a foundation for theory-driven research on the role of nanomaterials in living systems, mechanisms of homeopathic remedy actions and translational uses in nanomedicine.
Full-text available
Medicinal plant complexes of different species sharing vernacular names, morphological and aromatic characteristics and uses are common in traditional medicine of different cultures. A quantitative methodology as a tool for ethnopharmacological studies is presented for systematically analyzing morphological and therapeutic features shared by several species integrating such complexes. The aim of this paper is to apply a novel methodology to determine whether complexes are homogeneous and species within the complexes are completely interchangeable or not. Moreover, to find out if those species giving the name to the complex are also those which provide a large number of complex descriptors. For this purpose we study the complex of medicinal plant species which share the vernacular name "Árnica" in the Iberian Peninsula and the Balearic Islands, through the systematic recording of past and current local therapeutic uses and administration forms, plant-parts and localities where the different species are used. Being a newly introduced name in the region, "Árnica" offers an interesting field to study the genesis and dynamics of ethnopharmacological categories and medicinal plant complexes. A systematic review of the botanical, ethnobotanical and ethnopharmacological literature from 1895 to 2010 and of databases was performed in order to obtain information on the use of plants locally named as "Árnica" or with binomials that include the word "Árnica", in the Iberian Peninsula and the Balearic Islands. The "Árnica" complex includes 32 different plant species in the Iberian Peninsula, belonging to six families of Angiosperms, which partially share morphological characteristics and therapeutic properties. These are some of the most popular medicinal species of the Iberian Peninsula and are mainly used to treat inflammation, wounds, hematoma, and contusion. The vegetal materials are primarily macerated or decocted, and the methods of administration are plasters, washes, frictions or direct application of the plant. Medicinal plant complexes are frequent in ethnopharmacological contexts and require being clearly detected, and systematically studied. Plant species within each complex are only partly interchangeable because the sharing of characters, including medicinal uses, is low. "Árnica" medicinal plant complex is extremely dynamic in the Iberian Peninsula. In less than two hundred years up to 32 different plant species belonging to six different plant families became labeled "Árnica". Medical staff was extremely influential in the adoption of "Árnica" as a vernacular name between 1785 and 1864 in Spain and Portugal but not in the repertory of uses adopted for the plants within the complex. In terms of total descriptors shared in the complex, Arnica montana L. is less relevant than other three species, belonging to the Inuleae Cass. tribe, of the Asteraceae (Chiliadenus glutinosus (L.) Fourr., Inula montana L. and Dittrichia viscosa (L.) Greuter). Thus "Árnica" complex is labeled by three different Inuleae Cass. species and receives the name from a fourth Madieae Jeps. species (Arnica montana L.).
The pharmacodynamics aspects of homeopathic remedies are appraised by laboratory studies on the biological effects at various levels (cellular, molecular and systemic). The major question is how these medicines may work in the body. The possible answers concern the identification of biological targets, the means of drug-receptor interactions, the mechanisms of signal transmission and amplification, and the models of inversion of effects according to the traditional 'simile' rule. These problems are handled by two experimental and theoretical lines, according to the doses or dilutions considered (low-medium versus high dilutions). Homeopathic formulations in low-medium dilutions, containing molecules in the range of ultra-low doses, exploit the extreme sensitivity of biological systems to exogenous and endogenous signals. Their effects are interpreted in the framework of hormesis theories and paradoxical pharmacology. The hypotheses regarding the action mechanisms of highly diluted/dynamized solutions (beyond Avogadro-Loschmidt limit) variously invoke sensitivity to bioelectromagnetic information, participation of water chains in signalling, and regulation of bifurcation points of systemic networks. High-dilution pharmacology is emerging as a pioneering subject in the domain of nanomedicine and is providing greater plausibility to the puzzling claims of homeopathy.
Several lines of evidence suggest that homeopathic high dilutions (HDs) can effectively have a pharmacological action, and so cannot be considered merely placebos. However, until now there has been no unified explanation for these observations within the dominant paradigm of the dose-response effect. Here the possible scenarios for the physicochemical nature of HDs are reviewed. A number of theoretical and experimental approaches, including quantum physics, conductometric and spectroscopic measurements, thermoluminescence, and model simulations investigated the peculiar features of diluted/succussed solutions. The heterogeneous composition of water could be affected by interactive phenomena such as coherence, epitaxy and formation of colloidal nanobubbles containing gaseous inclusions of oxygen, nitrogen, carbon dioxide, silica and, possibly, the original material of the remedy. It is likely that the molecules of active substance act as nucleation centres, amplifying the formation of supramolecular structures and imparting order to the solvent. Three major models for how this happens are currently being investigated: the water clusters or clathrates, the coherent domains postulated by quantum electrodynamics, and the formation of nanoparticles from the original solute plus solvent components. Other theoretical approaches based on quantum entanglement and on fractal-type self-organization of water clusters are more speculative and hypothetical. The problem of the physicochemical nature of HDs is still far from to be clarified but current evidence strongly supports the notion that the structuring of water and its solutes at the nanoscale can play a key role.
Alcoholic extracts prepared form Arnicae flos, the collective name for flowerheads from Arnica montana and A. chamissonis ssp. foliosa, are used therapeutically as anti-inflammatory remedies. The active ingredients mediating the pharmacological effect are mainly sesquiterpene lactones, such as helenalin, 11 alpha,13-dihydrohelenalin, chamissonolid and their ester derivatives. While these compounds affect various cellular processes, current data do not fully explain how sesquiterpene lactones exert their anti-inflammatory effect. We show here that helenalin, and, to a much lesser degree, 11 alpha,13-dihydrohelenalin and chamissonolid, inhibit activation of transcription factor NF-kappa B. This difference in efficacy, which correlates with the compounds' anti-inflammatory potency in vivo, may be explained by differences in structure and conformation. NF-kappa B, which resides in an inactive, cytoplasmic complex in unstimulated cells, is activated by phosphorylation and degradation of its inhibitory subunit, I kappa B. Helenalin inhibits NF-kappa B activation in response to four different stimuli in T-cells, B-cells and epithelial cells and abrogates kappa B-driven gene expression. This inhibition is selective, as the activity of four other transcription factors, Oct-1, TBP, Spl and STAT 5 was not affected. We show that inhibition is not due to a direct modification of the active NF-kappa B heterodimer. Rather, helenalin modifies the NF-kappa B/I kappa B complex, preventing the release of I kappa B. These data suggest a molecular mechanism for the anti-inflammatory effect of sesquiterpene lactones, which differs from that of other nonsteroidal anti-inflammatory drugs (NSAIDs), indomethacin and acetyl salicylic acid.
To analyze the effect of homeopathic Arnica on mitochondrial oxidative stress induced by Ca(2+) plus inorganic phosphate and/or Fe(2+)-citrate-mediated lipid peroxidation through changes in oxygen consumption rates. Mitochondria were isolated by differential centrifugation from the livers of adult male Wistar rats which had been treated with Arnica montana 6cH, 12cH, 30cH or succussed 30% ethanol (control) for 21 days. In the presence of antimycin-A, electron transport chain inhibitor, as evidenced by antimycin-A insensitive O(2) consumption, Arnica inhibited lipid peroxidation of mitochondrial membranes. In oxidative stress conditions, in the presence of Ca(2+) and inorganic phosphate, animals receiving Arnica 30cH had a significant decrease in mitochondrial O(2) consumption compared to control animals. When administrated orally, Arnica 30cH protects against hepatic mitochondrial membrane permeabilization induced by Ca(2+) and/or Fe(2+)-citrate-mediated lipid peroxidation and fragmentation of proteins due to the attack by reactive oxygen species.
This study evaluated the wound healing activity of microcurrent application alone or in combination with topical Hypericum perforatum L. and Arnica montana L. on skin surgical incision surgically induced on the back of Wistar rats. The animals were randomly divided into six groups: (1) no intervention (control group); (2) microcurrent application (10 μA/2 min); (3) topical application of gel containing H. perforatum; (4) topical application of H. perforatum gel and microcurrent (10 μA/2 min); (5) topical application of gel containing A. montana; (6) topical application of A. montana gel and microcurrent (10 μA/2 min). Tissue samples were obtained on the 2nd, 6th and 10th days after injury and submitted to structural and morphometric analysis. Differences in wound healing were observed between treatments when compared to the control group. Microcurrent application alone or combined with H. perforatum gel or A. montana gel exerted significant effects on wound healing in this experimental model in all of the study parameters (P<0.05) when compared to the control group with positive effects seen regarding newly formed tissue, number of newly formed blood vessels and percentage of mature collagen fibers. The morphometric data confirmed the structural findings. In conclusion, application of H. perforatum or A. montana was effective on experimental wound healing when compared to control, but significant differences in the parameters studied were only observed when these treatments were combined with microcurrent application.